BioSpace News Archive

BioCapital

Micromet to Present at Two Upcoming Investor Conferences

June 6, 2011
·
1 min read
BioCapital

Northwest Biotherapeutics Announces Series of Financing Arrangements

June 6, 2011
·
5 min read
Deals

Grifols Announces the Completion of its Acquisition of Talecris Biotherapeutics and the Listing of its ADSs on NASDAQ

June 6, 2011
·
2 min read
Policy

Incyte Corporation Submits New Drug Application for Ruxolitinib in Myelofibrosis to the US FDA

June 6, 2011
·
1 min read
Drug Development

United Therapeutics Corporation’s FREEDOM-M Phase 3 Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Meets Primary Endpoint

June 6, 2011
·
12 min read
Genetown

PerkinElmer, Inc. Launches AxION(TM) Mass Spectrometry Platform

June 6, 2011
·
1 min read
Drug Development

Argos Therapeutics, Inc. Presents New Phase 2 Data Showing its Arcelis™ Immunotherapy AGS-003 in Combination with sunitinib Improves Progression-Free Survival (PFS) in Patients with Advanced Renal Cell Carcinoma (RCC)

June 6, 2011
·
3 min read
Drug Development

YM BioSciences Reports Interim Phase I/II Data for its JAK1/JAK2 Inhibitor CYT387 at American Society of Clinical Oncology

June 6, 2011
·
10 min read
Drug Development

Regeneron Pharmaceuticals, Inc.'s ZALTRAP(TM) (aflibercept) Significantly Improved Survival in Previously Treated Metastatic Colorectal Cancer Patients

June 6, 2011
·
9 min read
Drug Development

Cell Therapeutics, Inc. Release: Treatment with OPAXIO(R) (Paclitaxel Poliglumex),Temozolomide and Radiotherapy Results in Encouraging Progression Free Survival in Patients With High Grade Malignant Brain Tumors

June 6, 2011
·
5 min read